A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants - Concepedia

Concepedia

Publication | Closed Access

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

721

Citations

36

References

2006

Year

Sung Eun Sim, Carl Risinger, Eleni Aklillu, Mette Krogh Christensen, Leif Bertilsson, Magnus Ingelman‐Sundberg

Clinical Pharmacology & Therapeutics

Abstract

CYP2C19*17 is likely to cause therapeutic failures in drug treatment with, for example, proton pump inhibitors and antidepressants.

References

	Year	Citations

Page 1